Name Card
rp00231 picture

Professor Wong, Chun Ming 黃俊銘

Title:
Professor

Department:
Department of Pathology

Faculty:
Li Ka Shing Faculty of Medicine

Principal Investigator
StatusProject CodeProject TitleAmountFunding Year
 
2023A1515012376組蛋白伴侶YL1/VPS72失調在肝癌中的功能與病理學意義1000002023
 
17113723Deregulation of RNA N4-acetylcytidine modification promotes liver cancer development15450122023
 
08192116BRD9 deregulation in liver cancer: Pathological significance and therapeutic potentials15000002020
 
17112621Delineating the role of histone chaperon complex CAF-1 in liver cancer11756122021
 
17108720The role of FACT complex in the hypoxia adaptation in liver cancer11954222020
 
07181956Pathological roles of BRPF1 deregulation and its therapeutic implications in liver cancer14997442019
 
81872039Deregulation of tRNA methyltransferase TRMT6 in liver cancer and its functional roles7159202018
 
06171586Genome-scale CRISPR/Cas9 knockout library screening identified druggable targets to overcome Lenvatinib resistance in liver cancer14999962018
 
17115815Pathological roles of chromatin remodeling protein, HELLS, in liver carcinogenesis and its implications in cancer metabolic reprogramming9182052015
 
05161786Pathological significances and therapeutic potential of targeting FACT complex in liver cancer11300482017
 
HKU 780612MDeregulation of SETDB1 and its functional roles in liver cancer11582502012
 
HKU 782411MPolycomb silencing and microRNA deregulation in liver cancer7500002011
 
HKU 778508MRoles of histone methyltransferases SUV39H1 and SUV39H2 in liver cancer8975782008
 
81572446Clinicopathological significance and functional roles of G9a up-regulation in Hepatocellular Carcinoma7159202015
 
03142996Pathological implications and functional characterizations of novel long non-coding RNA linc-CHD1L-1 in hepatocellular carcinoma11176082015
 
03142986Deregulation and somatic mutations of histone methyltransferase ASH1L in liver cancer.11696082015
 
17142516Deregulation and pathological implications of RNA N6-adensoine methyltransferase METTL3 in liver carcinogenesis11310312016
 
04150856Therapeutic potential of targeting CDK7-dependent and super-enhancer associated oncogene addiction in liver cancer9628562016
Co-Investigator
StatusProject CodeProject TitleAmountFunding Year
 
T12-716/22-R Delineating and translating the mechanistic determinants to improve the clinical management of liver cancer332685562022
 
10212786Characterization of CASC11, a long noncoding RNA (LncRNA) as a new generation of RNA therapeutics in hepatocellular carcinoma15000002023
 
C7016-22GDevelopment of Chemical Probes for YEATS2 and Their Uses in Mechanistic and Pharmacological Studies85500002022
 
C7008-22GThe immune microenvironment of recurrent hepatocellular carcinoma72000002022
 
05163566Pathological roles of Bromodomain and Extra-Terminal (BET) proteins and their therapeutic implications in liver cancer11980482017
 
04150776Characterization of a novel tumor suppressive long non-coding RNA linc-ALDH1A2-1 in hepatocellular carcinoma11999562016
 
InP/287/13Development of A Point-of-Care Early Liver Cancer Detector Using Magnetic Immunoassay (MIA)2167202013
 
N/AGenome-wide methylation screening in search for novel tumour suppressor genes in liver cancer15153712004
 
InP/280/13Development of A Point-of-Care Early Liver Cancer Detector Using Magnetic Immunoassay (MIA)2562702013
 
HKU 775811MSignificance of RhoE dysregulation in liver cancer and metastasis16059952011
 
HKU 771111MThe significance of Nucleophosmin (NPM) phosphorylation in the progression of hepatocellular carcinoma6500002011
 
ITS/104/13Development of a point-of-care early liver cancer detector using magnetic immunoassay (MIA)9970502013
 
T12-704/16-RUnderstanding Cancer Stemness in Liver Cancer – From Regulation to Translational Applications285234002016
 
HKU 7/CRF/09Molecular Pathology of Liver Cancer - a Multidisciplinary Study81000002009
 
81772644New therapeutic strategies involving TXNRD1 inhibitor in HCC treatment6908002017